Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.

PHASE2CompletedINTERVENTIONAL
Enrollment

1,059

Participants

Timeline

Start Date

November 30, 1996

Study Completion Date

September 30, 2004

Conditions
Breast Cancer
Interventions
DRUG

Anastrozole

oral

DRUG

Tamoxifen

oral

Trial Locations (43)

Unknown

Research Site, Albstadt

Research Site, Berlin

Research Site, Cloppenburg

Research Site, Eggenfelden

Research Site, Frankfurt

Research Site, Freiburg im Breisgau

Research Site, Göttingen

Research Site, Halle

Research Site, Hamburg

Research Site, Hanau

Research Site, Hanover

Research Site, Heidelberg

Research Site, Hoyerswerda

Research Site, Idar-Oberstein

Research Site, Jena

Research Site, Karlsruhe

Research Site, Kassel

Research Site, Kiel

Research Site, Leonberg

Research Site, Lingen

Research Site, Lübeck

Research Site, Magdeburg

Research Site, Mainz

Research Site, Mannheim

Research Site, München

Research Site, Münster

Research Site, Neustadt

Research Site, Osnabrück

Research Site, Paderborn

Research Site, Pforzheim

Research Site, Recklinghausen

Research Site, Rosenheim

Research Site, Rostock

Research Site, Rüsselsheim am Main

Research Site, Schleswig

Research Site, Siegen

Research Site, Titisee-Neustadt

Research Site, Tübingen

Research Site, Ulm

Research Site, Waiblingen

Research Site, Westerstede

Research Site, Worms

Research Site, Würzburg

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

German Adjuvant Breast Cancer Group

OTHER

lead

AstraZeneca

INDUSTRY